Collectively, both pharmacological and transcriptional inhibition of AMPK rescued growth and metabolic phenotypes of GPX8 loss, indicating that GPX8 exerts its effects in ccRCC through inhibition of AMPK, which is implicated in ccRCC growth and prognosis. The gene discussed is GPX8; the disease is nonpapillary renal cell carcinoma.